Table 1.
Overall rates of antibiotics susceptibility test of E. coli (n = 26) and K. pneumoniae isolates (n = 34) as determined by MicroScan.
| Antibiotics | R⁎n (%) |
I⁎n (%) |
S⁎n (%) |
ESBL⁎n (%) |
||||
|---|---|---|---|---|---|---|---|---|
| E. coli | K. pneum. | E. coli | K. pneum. | E. coli | K. pneum. | E. coli | K. pneum. | |
| Ertapenem | 3 (11.5) | 24 (70.5) | 0 | 0 | 23 (88.4) | 10 (29.4) | 0 | 0 |
| Imipenem | 3 (11.5) | 11 (32.3) | 1 (3.8) | 6 (17.6) | 22 (84.6) | 17 (50) | 0 | 0 |
| Meropenem | 2 (7.6) | 12 (35.2) | 0 | 2 (5.8) | 24 (92.3) | 20 (58.8) | 0 | 0 |
| Amikacin | 2 (7.6) | 12 (35.2) | 0 | 10 (29.4) | 24 (92.3) | 12 (35.2) | 0 | 0 |
| Amox/kclav | 9 (3.6) | 29 (85.8) | 5 (19) | 2 (5.8) | 12 (46.1) | 3 (8.8) | 0 | 0 |
| Ampicillin | 25 (96) | 33 (97) | 0 | 0 | 1 (3.8) | 1 (2.9) | 0 | 0 |
| Cefepime | 25 (96) | 27 (79) | 0 | 1 (2.9) | 1 (3.8) | 6 (17.6) | 0 | 0 |
| Cefotaxime | 4 (15.3) | 17 (50) | 0 | 0 | 1 (3.8) | 6 (17.6) | 21 (80.7) | 11 (32.3) |
| Ceftazidime | 4 (15.3) | 16 (47) | 0 | 0 | 1 (3.8) | 6 (17.6) | 21 (80.7) | 12 (35.2) |
| Cefuroxime | 25 (96) | 32 (94) | 0 | 0 | 1 (3.8) | 2 (5.8) | 0 | 0 |
| Ciprofloxacin | 15 (57.6) | 29 (85) | 0 | 0 | 11 (42.3) | 5 (14.7) | 0 | 0 |
| Gentamicin | 15 (57.6) | 23 (67.6) | 1 (3.8) | 0 | 10 (38.4) | 11 (32.3) | 0 | 0 |
| PipTzo | 6 (23) | 27 (79) | 1 (3.8) | 1 (2.9) | 19 (73) | 6 (17.6) | 0 | 0 |
| TrimethSulfa | 16 (61.5) | 18 (53.9) | 0 | 0 | 10 (41.2) | 16 (47) | 0 | 0 |
⁎
(S = sensitive, R = resistant, I = intermediate, ESBL = Extended spectrum beta-lactamase).